2.15
-0.03(-1.38%)
Currency In USD
| Previous Close | 2.18 |
| Open | 2.1 |
| Day High | 2.18 |
| Day Low | 2.07 |
| 52-Week High | 16.94 |
| 52-Week Low | 1.26 |
| Volume | 133,029 |
| Average Volume | 193,868 |
| Market Cap | 56.24M |
| PE | -0.25 |
| EPS | -8.52 |
| Moving Average 50 Days | 1.55 |
| Moving Average 200 Days | 2.82 |
| Change | -0.03 |
If you invested $1000 in Senti Biosciences, Inc. (SNTI) since IPO date, it would be worth $21.54 as of October 19, 2025 at a share price of $2.15. Whereas If you bought $1000 worth of Senti Biosciences, Inc. (SNTI) shares 3 years ago, it would be worth $77.9 as of October 19, 2025 at a share price of $2.15.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Senti Bio to Present at Chardan's 9th Annual Genetic Medicines Conference
GlobeNewswire Inc.
Oct 16, 2025 1:05 PM GMT
Live webcast presentation on Tuesday, October 21st at 11:35 AM ETSOUTH SAN FRANCISCO, Calif., Oct. 16, 2025 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio”), a clinical-stage biotechnology company developing next-generation
Senti Bio to Present at BioJapan
GlobeNewswire Inc.
Oct 06, 2025 1:05 PM GMT
In-person presentation on Thursday, October 9th at 11:30 AM JSTSOUTH SAN FRANCISCO, Calif., Oct. 06, 2025 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio”), a clinical-stage biotechnology company developing next-generation ce
Senti Bio to Present at the MedInvest Biotech & Pharma Conference
GlobeNewswire Inc.
Sep 18, 2025 1:15 PM GMT
Live webcast presentation on Wednesday, September 24th at 9:55 AM PTSOUTH SAN FRANCISCO, Calif., Sept. 18, 2025 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio”), a clinical-stage biotechnology company developing next-generat